# Ciprofloxacin Versus an Aminoglycoside Followed by Ciprofloxacin for Bubonic Plague

> **NCT04110340** · PHASE3 · COMPLETED · sponsor: **University of Oxford** · enrollment: 222 (actual)

## Conditions studied

- Plague, Bubonic
- Plague, Pneumonic

## Interventions

- **DRUG:** Ciprofloxacin
- **DRUG:** Streptomycin
- **DRUG:** Gentamicin

## Key facts

- **NCT ID:** NCT04110340
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-15
- **Primary completion:** 2024-04-30
- **Final completion:** 2025-02-05
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2025-03-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04110340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04110340, "Ciprofloxacin Versus an Aminoglycoside Followed by Ciprofloxacin for Bubonic Plague". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04110340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*